Piperidine derivative used for treating chemokine receptor 5...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/14 (2006.01) A61K 31/4545 (2006.01) A61P 31/12 (2006.01)

Patent

CA 2671460

The present invention relates to 4-[3-(1,1-difluoroethyl)-5-methyl-4H-1,2,4-triazol- 4-yl]-1-{(1R,3R)-3-(3,5-difluorophenyl)-1-methyl-3-[1-(methylsulfonyl).rho.iperidin-4- yl]propyl}piperidine formula (I): or a pharmaceutically acceptable salt thereof, as well as processes for the preparation of this compound and its use in the treatment of CCR5 disease states.

La présente invention concerne une 4-[3-(l,l-difluoroéthyl)-5-méthyl-4H-l,2,4-triazol-4-yl]-l-{(lJR,3i?)-3-(3,5-difluorophényl)-l-méthyl-3-[l-(méthylsulfonyl).rho.ipéridin-4-yl]propyl}pipéridine (I) : ou l'un de ses sels acceptables d'un point de vue pharmaceutique, ainsi que des procédés de préparation de ce composé et son utilisation dans le traitement d'états pathologiques du CCR5.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Piperidine derivative used for treating chemokine receptor 5... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidine derivative used for treating chemokine receptor 5..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivative used for treating chemokine receptor 5... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1989214

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.